SABCS 2022 Conference Coverage


 

SABCS 2022 10-Year Results of a Phase 3 Trial of Low-Dose Tamoxifen in Non-Invasive Breast Cancer

1,497 views
December 15, 2022
Comments 0
Login to view comments. Click here to Login